Marle

Leading European contract manufacturing organisation (CMO) of hip and knee orthopaedic implants

Established in 1964 as a family business, Marle (“the Company”) is the European leader in orthopaedic implants with over 2 million implants produced annually. The Company provides specialised manufacturing services for the production of a wide range of hip, knee, shoulder, spine and extremities implants as well as orthopaedic instruments of the highest quality.

Marle has mastered the full range of hip and knee implants production technology: prototyping, manufacturing and finishing. The Company’s products are sold to major global OEM players as well as share-winning challengers, across Europe, the US, and Asia. Headquartered in Nogent, France, Marle runs eleven certified production sites in France, Switzerland and the US.

In December 2019, IK Partners reinvested in Marle alongside Dentressangle.

What Attracted us to the Business

• Growing and non-cyclical underlying implant market
• Captive business model
• Predictable revenues
• Strong position as key pure medical technology player

Our Value Creation Strategy

We are working alongside management to:

• Further expansion of the product offering by penetrating the down-stream and knee segments;
• Leverage existing client base and further develop a one-stop-shop technology offering;
• Pursue international expansion by focusing on the US organically or via acquisitions; and
• Target transitioning from a European leader to a Global CMO leadership.